RSPO4
R-spondin-4
Also known as: C20orf182, dJ824F16.3, RSPO4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2I0M5
- Gene
- RSPO4
- Ensembl
- ENSG00000101282
- Chromosome
- 20
- Canonical length
- 234 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene encodes a member of the R-spondin family of proteins that share a common domain organization consisting of a signal peptide, cysteine-rich/furin-like domain, thrombospondin domain and a C-terminal basic region. The encoded protein may be involved in activation of Wnt/beta-catenin signaling pathways. Mutations in this gene are associated with anonychia congenital. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
234 residues, UniProt reviewed canonical sequence.
>Q2I0M5|RSPO4
1 MRAPLCLLLL VAHAVDMLAL NRRKKQVGTG LGGNCTGCII CSEENGCSTC QQRLFLFIRR
61 EGIRQYGKCL HDCPPGYFGI RGQEVNRCKK CGATCESCFS QDFCIRCKRQ FYLYKGKCLP
121 TCPPGTLAHQ NTRECQGECE LGPWGGWSPC THNGKTCGSA WGLESRVREA GRAGHEEAAT
181 CQVLSESRKC PIQRPCPGER SPGQKKGRKD RRPRKDRKLD RRLDVRPRQP GLQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RSPO4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- lung: 12 nTPM
- hypothalamus: 8.2 nTPM
- basal ganglia: 5.6 nTPM
- midbrain: 4.1 nTPM
- hippocampal formation: 2.9 nTPM
- testis: 2.9 nTPM
Single-cell type
- ependymal cells: 52 nCPM
- late spermatids: 25 nCPM
- other brain neurons: 22 nCPM
- early spermatids: 21 nCPM
- astrocytes: 20 nCPM
- gonadotrophs: 15 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 27 nTPM
- medulla oblongata: 20 nTPM
- hypothalamus: 19 nTPM
- midbrain: 18 nTPM
- thalamus: 17 nTPM
- cerebral cortex: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RSPO4.
Disease | AllUniProt
Conditions RSPO4 is implicated in, by any mechanism.
- Nail disorder, non-syndromic congenital, 4 (NDNC4) MIM:206800
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 88 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.59
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.47
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- nail development
- positive regulation of canonical Wnt signaling pathway
- positive regulation of Wnt signaling pathway
- Wnt signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RSPO4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RSPO4 as an antibody target. Whether an autoantibody or antibody against RSPO4 could matter depends on whether native RSPO4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RSPO4 is annotated as secreted, so native RSPO4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label RSPO4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...